Found: 74
Select item for more details and to access through your institution.
Protective Effects of Increasing Vitamin E and A Doses on Cisplatin-Induced Oxidative Damage to Kidney Tissue in Rats.
- Published in:
- Urologia Internationalis, 2005, v. 75, n. 4, p. 340, doi. 10.1159/000089171
- By:
- Publication type:
- Article
Inhibition of 6-phosphogluconate Dehydrogenase Reverses Cisplatin Resistance in Ovarian and Lung Cancer.
- Published in:
- Frontiers in Pharmacology, 2017, p. 1, doi. 10.3389/fphar.2017.00421
- By:
- Publication type:
- Article
Oxytocin alleviates cisplatin-induced renal damage in rats.
- Published in:
- Iranian Journal of Basic Medical Sciences, 2014, v. 17, n. 10, p. 747
- By:
- Publication type:
- Article
Safety, efficacy, and patient acceptability of single-dose fosaprepitant regimen for the prevention of chemotherapy-induced nausea and vomiting.
- Published in:
- Patient Preference & Adherence, 2013, v. 7, p. 391, doi. 10.2147/PPA.S31288
- By:
- Publication type:
- Article
Oral mucosal side effects of cytotoxic chemotherapy of testicular cancer.
- Published in:
- European Journal of Oral Sciences, 1997, v. 105, n. 5p2, p. 523, doi. 10.1111/j.1600-0722.1997.tb00239.x
- By:
- Publication type:
- Article
Conventional vs concomitant boost radiotherapy with concurrent cisplatin in advanced head and neck cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Celecoxib Potentiates the Anticancer Effect of Cisplatin on Vulvar Cancer Cells Independently of Cyclooxygenase.
- Published in:
- Annals of the New York Academy of Sciences, 2009, v. 1171, p. 635, doi. 10.1111/j.1749-6632.2009.04888.x
- By:
- Publication type:
- Article
Protective effect of selenium on cisplatin induced nephrotoxicity: A double-blind controlled randomized clinical trial.
- Published in:
- Journal of Nephropathology, 2013, v. 2, n. 2, p. 129, doi. 10.5812/nephropathol.10656
- By:
- Publication type:
- Article
Effects of Antioxidant Herbs on Chemotherapy-Induced Nausea and Vomiting in a Rat-Pica Model.
- Published in:
- American Journal of Chinese Medicine, 2004, v. 32, n. 6, p. 897, doi. 10.1142/S0192415X04002508
- By:
- Publication type:
- Article
Lipoplatin Treatment in Lung and Breast Cancer.
- Published in:
- Chemotherapy Research & Practice, 2011, p. 1, doi. 10.1155/2011/125192
- By:
- Publication type:
- Article
Nephroprotective Effects of Saponins from Leaves of Panax quinquefolius against Cisplatin-Induced Acute Kidney Injury.
- Published in:
- International Journal of Molecular Sciences, 2017, v. 18, n. 7, p. 1407, doi. 10.3390/ijms18071407
- By:
- Publication type:
- Article
Thermoanalytical study about histidine and cysteine-cadmium interactions.
- Published in:
- Journal of Thermal Analysis & Calorimetry, 2003, v. 74, n. 3, p. 923, doi. 10.1023/B:JTAN.0000011024.89077.43
- By:
- Publication type:
- Article
Salvia Officinalis and Cisplatin Effects on Pentylenetetrazole Induced Seizure Threshold.
- Published in:
- Zahedan Journal of Research in Medical Sciences, 2013, v. 15, n. 11, p. 1
- By:
- Publication type:
- Article
Human and mouse mesotheliomas exhibit elevated AKT/PKB activity, which can be targeted pharmacologically to inhibit tumor cell growth.
- Published in:
- Oncogene, 2005, v. 24, n. 40, p. 6080, doi. 10.1038/sj.onc.1208744
- By:
- Publication type:
- Article
A p53-dominant transcriptional response to cisplatin in testicular germ cell tumor-derived human embyronal carcinoma.
- Published in:
- Oncogene, 2005, v. 24, n. 40, p. 6090, doi. 10.1038/sj.onc.1208755
- By:
- Publication type:
- Article
Inositol 1,4,5-trisphosphate (IP<sub>3</sub>) receptor type1 (IP<sub>3</sub>R1) modulates the acquisition of cisplatin resistance in bladder cancer cell lines.
- Published in:
- Oncogene, 2005, v. 24, n. 8, p. 1396, doi. 10.1038/sj.onc.1208313
- By:
- Publication type:
- Article
In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: implications for cancer therapy.
- Published in:
- Oncogene, 2005, v. 24, n. 6, p. 970, doi. 10.1038/sj.onc.1208316
- By:
- Publication type:
- Article
p12<sup>CDK2-AP1</sup> mediates DNA damage responses induced by cisplatin.
- Published in:
- Oncogene, 2005, v. 24, n. 3, p. 407, doi. 10.1038/sj.onc.1208222
- By:
- Publication type:
- Article
Possible role of FLICE-like inhibitory protein (FLIP) in chemoresistant ovarian cancer cells in vitro.
- Published in:
- Oncogene, 2004, v. 23, n. 42, p. 6997, doi. 10.1038/sj.onc.1207925
- By:
- Publication type:
- Article
Adjuvant Chemotherapy with Cisplatin for Lung Cancer.
- Published in:
- American Family Physician, 2004, v. 70, n. 5, p. 977
- By:
- Publication type:
- Article
The Potent Oxidant Anticancer Activity of Organoiridium Catalysts.
- Published in:
- Angewandte Chemie International Edition, 2014, v. 53, n. 15, p. 3941, doi. 10.1002/anie.201311161
- By:
- Publication type:
- Article
The effect of different doses of cisplatin on the pharmacokinetic parameters of cefepime in mice.
- Published in:
- Laboratory Animals, 2006, v. 40, n. 3, p. 296
- By:
- Publication type:
- Article
WR-2721 (Amifostine) ameliorates cisplatin-induced hearing loss but causes neurotoxicity in hamsters: dose-dependent effects.
- Published in:
- 2004
- By:
- Publication type:
- journal article
Inhibition of basolateral transport and cellular accumulation of cDDP and N-acetyl-L-cysteine-cDDP by TEA and PAH in the renal proximal tubule.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2003, v. 51, n. 2, p. 132, doi. 10.1007/s00280-002-0537-0
- By:
- Publication type:
- Article
Decreased cisplatin/DNA adduct formation is associated with cisplatin resistance in human head and neck cancer cell lines.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2000, v. 46, n. 4, p. 255, doi. 10.1007/s002800000167
- By:
- Publication type:
- Article
Combined effects of the orally active cisplatin analog, JM216, and radiation in antitumor therapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2000, v. 46, n. 5, p. 423, doi. 10.1007/s002800000169
- By:
- Publication type:
- Article
Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2000, v. 45, n. 3, p. 199, doi. 10.1007/s002800050030
- By:
- Publication type:
- Article
Chimiothérapie des carcinomes urothéliaux infiltrants de vessie.
- Published in:
- Oncologie (Tech Science Press), 2004, v. 6, n. 4, p. 263, doi. 10.1007/s10269-004-0062-3
- By:
- Publication type:
- Article
Clinical Significance of UDP-Glucuronosyltransferase 1A1*6 for Toxicities of Combination Chemotherapy with Irinotecan and Cisplatin in Gynecologic Cancers.
- Published in:
- Oncology, 2009, v. 76, n. 5, p. 315, doi. 10.1159/000209335
- By:
- Publication type:
- Article
Renal epithelial gene expression profile and bismuth-induced resistance against cisplatin nephrotoxicity.
- Published in:
- Human & Experimental Toxicology, 2003, v. 22, n. 10, p. 535, doi. 10.1191/0960327103ht393oa
- By:
- Publication type:
- Article
Establishment of Stable hFis1 Knockdown Cells with an siRNA Expression Vector.
- Published in:
- Journal of Biochemistry, 2004, v. 136, n. 4, p. 421, doi. 10.1093/jb/mvh139
- By:
- Publication type:
- Article
Mutant Nbs1 enhances cisplatin-induced DNA damage and cytotoxicity in head and neck cancer
- Published in:
- Otolaryngology-Head & Neck Surgery, 2004, v. 131, n. 4, p. 477, doi. 10.1016/j.otohns.2004.04.019
- By:
- Publication type:
- Article
Weekly paclitaxel, cisplatin, and radiation in advanced head and neck cancer (AHNC)
- Published in:
- 2004
- By:
- Publication type:
- Abstract
Whole-body hyperthermia in combination with platinum-containing drugs in patients with recurrent ovarian cancer.
- Published in:
- International Journal of Clinical Oncology, 2004, v. 9, n. 2, p. 85, doi. 10.1007/s10147-003-0369-x
- By:
- Publication type:
- Article
Population Pharmacokinetics of Cycloplatam. II. Clinical Monitoring of the Drug Pharmacokinetics Upon Short and Long-Term Infusion.
- Published in:
- Pharmaceutical Chemistry Journal, 2003, v. 37, n. 11, p. 567, doi. 10.1023/B:PHAC.0000016063.69437.c6
- By:
- Publication type:
- Article
Magnetic properties of electrons in metal–ammonia solutions.
- Published in:
- Technical Physics, 1997, v. 42, n. 8, p. 855, doi. 10.1134/1.1258747
- By:
- Publication type:
- Article
Comparative Study Between Two Treatment Regimens of Cisplatin-5- Fluorouracil and Gemcitabine-Cisplatin in Gallbladder Cancer Patients.
- Published in:
- Iranian Journal of Pharmaceutical Research, 2017, v. 16, n. 2, p. 795
- By:
- Publication type:
- Article
Balance between MKK6 and MKK3 Mediates p38 MAPK Associated Resistance to Cisplatin in NSCLC.
- Published in:
- PLoS ONE, 2011, v. 6, n. 12, p. 1, doi. 10.1371/journal.pone.0028406
- By:
- Publication type:
- Article
Intracellular Kinases Mediate Increased Translation and Secretion of Netrin-1 from Renal Tubular Epithelial Cells.
- Published in:
- PLoS ONE, 2011, v. 6, n. 10, p. 1, doi. 10.1371/journal.pone.0026776
- By:
- Publication type:
- Article
CCND1 as a Predictive Biomarker of Neoadjuvant Chemotherapy in Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma.
- Published in:
- PLoS ONE, 2011, v. 6, n. 10, p. 1, doi. 10.1371/journal.pone.0026399
- By:
- Publication type:
- Article
A Gene Expression Signature of Acquired Chemoresistance to Cisplatin and Fluorouracil Combination Chemotherapy in Gastric Cancer Patients.
- Published in:
- PLoS ONE, 2011, v. 6, n. 2, p. 1, doi. 10.1371/journal.pone.0016694
- By:
- Publication type:
- Article
The Schizosaccharomyces pombe Checkpoint Kinases Chk1 and Cds1 Are Important for Cell Survival in Response to Cisplatin.
- Published in:
- PLoS ONE, 2009, v. 4, n. 7, p. 1, doi. 10.1371/journal.pone.0006181
- By:
- Publication type:
- Article
Expression of survivin mRNA and protein in gastric cancer cell line (MKN-45) during cisplatin treatment.
- Published in:
- Apoptosis, 2002, v. 7, n. 1, p. 23, doi. 10.1023/A:1013556727182
- By:
- Publication type:
- Article
A Randomized Comparative Study of Antiemetic Prophylaxis with Ondansentron in a Single 32-mg Loading Dose versus 8 mg Every 6 h in Patients Undergoing Cisplatin-Based Chemotherapy.
- Published in:
- Oncology, 1998, v. 55, n. 6, p. 513, doi. 10.1159/000011904
- By:
- Publication type:
- Article
Effects of cis-Diamminedichloroplatinum(II) on Escherichia coli and Bacteriophage Systems.
- Published in:
- Journal of Biochemistry, 1998, v. 123, n. 5, p. 821, doi. 10.1093/oxfordjournals.jbchem.a022010
- By:
- Publication type:
- Article
Interactions of cisplatin with calcium phosphate nanoparticles: in vitro controlled adsorption and release
- Published in:
- Journal of Orthopaedic Research, 2004, v. 22, n. 4, p. 703, doi. 10.1016/j.orthres.2003.10.016
- By:
- Publication type:
- Article
Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Study of the one-dimensional periodic polaron structures.
- Published in:
- Journal of Nanoparticle Research, 2011, v. 13, n. 11, p. 6113, doi. 10.1007/s11051-011-0457-1
- By:
- Publication type:
- Article
Reversal of acquired cisplatin resistance by modulation of metallothionein in transplanted murine tumors.
- Published in:
- International Journal of Urology, 2004, v. 11, n. 6, p. 407, doi. 10.1111/j.1442-2042.2004.00803.x
- By:
- Publication type:
- Article
Effect of Chemoradiotherapy with Gemcitabine and Cisplatin on Locoregional Control in Patients with Primary Inoperable Pancreatic Cancer.
- Published in:
- World Journal of Surgery, 2004, v. 28, n. 10, p. 1011, doi. 10.1007/s00268-004-7338-z
- By:
- Publication type:
- Article